Meyer Handelman Co. Lowers Stock Position in Cigna Group $CI

Meyer Handelman Co. trimmed its holdings in Cigna Group (NYSE:CIFree Report) by 53.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,193 shares of the health services provider’s stock after selling 5,982 shares during the quarter. Meyer Handelman Co.’s holdings in Cigna Group were worth $1,429,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Fifth Third Wealth Advisors LLC increased its stake in Cigna Group by 13.4% in the fourth quarter. Fifth Third Wealth Advisors LLC now owns 3,175 shares of the health services provider’s stock valued at $874,000 after purchasing an additional 375 shares during the period. Birch Financial Group LLC boosted its stake in shares of Cigna Group by 94.8% during the fourth quarter. Birch Financial Group LLC now owns 1,880 shares of the health services provider’s stock worth $518,000 after buying an additional 915 shares during the period. apricus wealth LLC grew its holdings in shares of Cigna Group by 715.9% during the fourth quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock worth $2,616,000 after buying an additional 8,340 shares during the last quarter. Retirement Systems of Alabama grew its holdings in shares of Cigna Group by 9.6% during the fourth quarter. Retirement Systems of Alabama now owns 180,962 shares of the health services provider’s stock worth $49,806,000 after buying an additional 15,858 shares during the last quarter. Finally, Polianta Ltd purchased a new position in shares of Cigna Group during the fourth quarter worth about $1,568,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several analysts have commented on CI shares. Barclays reduced their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research note on Friday, February 6th. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Truist Financial increased their price target on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research report on Tuesday, February 10th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $333.11.

Read Our Latest Stock Analysis on CI

Cigna Group Stock Up 3.3%

CI opened at $266.54 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The stock has a market capitalization of $70.24 billion, a P/E ratio of 12.02, a P/E/G ratio of 0.89 and a beta of 0.27. The business has a 50 day simple moving average of $276.72 and a 200-day simple moving average of $279.57.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th were issued a $1.56 dividend. The ex-dividend date was Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is 28.13%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.